Nerve biologic products include artificial nerve conduit, nerve graft, nerve wraps, or nerve capping devices used for guiding axonal regrowth to facilitate nerve regeneration. These devices are majorly used in clinical treatments for nerve injuries. Nerve biologic products are commonly used for complex suturing, for instance suturing of two ends of a separated nerve that needs rigid process. The scaffold material used for generating nerve biologic products is either from synthetic or biological origin. The nerve biologic products are manufactured from various biocompatible products such as polysialic acid (PSA), collagen type I/III, spider silk fiber, silkworm silk fibroin, chitosan, aragonite, and alginate.
Request Sample of Report: https://www.coherentmarketinsights.com/insight/request-sample/2265
Nerve Biologic Products Market Drivers
Advancements in research and development for developing innovative technology for nerve biologic products are expected to drive growth of the nerve biologic product market. For instance, in February 2015, researchers from the University of Sheffield developed a device, 3D-printed nerve guidance conduit (NGC). NGC is a network of miniature tubes, which guide injured nerve ends towards each other, thereby enabling them to repair naturally. The device uses computer-aided design (CAD), which can be modified for any type of nerve damage or even adapted for joint specific nerves of patient.
Furthermore, in June 2016, Polyganics, a medical device manufacturing company, received the CE mark for Neurocap, its nerve capping device. Neurocap is an absorbable implant for treatment and reduction of symptomatic neuroma in peripheral nerves. The device was cleared for sales in the U.S. in January 2016.
Nerve Biologic Products Market – Regional Analysis
On the basis of region, the global nerve biologic products market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Based on region, North America is expected to hold lead position in the global nerve biologic products market during the forecast period, owing to rising number of peripheral nerve injuries in the U.S. For instance, according to Proceedings of the National Academy of Sciences of the U.S. study in June 2017, over 250,000 people from the U.S. suffers from peripheral nerve injury annually.
Key players operating in the global nerve biologic products market include, Stryker, AxoGen, Inc., Integra LifeSciences, Collagen Matrix, Inc., Polyganics, Checkpoint Surgical Inc., and TEXAS PHARMACUETICAL PVT LTD.
Nerve Biologic Products Market – Taxonomy
By Product Type:
Direct Nerve Repair/ Neurorrhaphy
Peripheral Nerve Injuries
Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/nerve-biologic-products-market-2265
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154